Global Small Molecule Innovator CDMO Market Size is valued at USD 51.2 Billion in 2024 and is predicted to reach USD 93.6 Billion by the year 2034 at a 6.3% CAGR during the forecast period for 2025-2034. The small molecule innovator CDMO (Contract Development and Manufacture Organization) market is a subset of the pharmaceutical business that provides contract services for small molecule drug development and manufacture. Small molecule pharmac...
Report ID: 1963 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Global Pharma Contract Commercialization (CCO) Market Size is valued at USD 42.6 Billion in 2024 and is predicted to reach USD 69.7 Billion by the year 2034 at a 5.1% CAGR during the forecast period for 2025-2034. A contract commercial organization (CCO) gives pharmaceutical businesses commercial services in order to boost performance, reduce risk, and speed up the transmission of medical innovation to patients. The main drivers of the pharma ...
Report ID: 2068 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 177
Fermentation Enabled Alternative Protein Market Size is valued at 472.91 Mn in 2024 and is predicted to reach 1768.38 Mn by the year 2034 at an 14.2% CAGR during the forecast period for 2025-2034. The alternative protein industry can be divided into three main areas: plant-based alternative proteins, cell-based alternative proteins, and fermentation-based alternative proteins. Fermentation-enabled alternative protein ...
Report ID: 1928 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
The Peptide CDMO (Pharmaceutical) Market Size is valued at 2.5 Bn in 2024 and is predicted to reach 6.6 Bn by the year 2034 at a 10.4% CAGR during the forecast period for 2025-2034. Peptides are bioactive molecules that bind to specific cell surface receptors, such as G protein-coupled receptors (GPCRs) or ion channels, where they trigger intracellular effects. Peptides have characteristics like safety, high specificit...
Report ID: 1202 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 175
Global Viral and Non-Viral Vector Manufacturing Market Size is valued at USD 8.0 Billion in 2024 and is predicted to reach USD 56.8 Billion by the year 2034 at a 21.9% CAGR during the forecast period for 2025-2034. Viral vectors are genetically modified viruses utilised as carriers for introducing exogenous genetic material into cells through their viral genome. In contrast, nonviral vectors encompass a range of chemical vectors, including ino...
Report ID: 1263 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 170
Biologics CDMO Market Size is valued at USD 24.2 Bn in 2024 and is predicted to reach USD 125.5 Bn by the year 2034 at a 18.1% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the report: The global Biologics CDMO market is poised for a significant growth, fueled by the increasing demand for biologics and biosimilars in the pharmaceutical industry. CDMOs are increasingly pivotal ...
Report ID: 2233 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Next-Generation Biomanufacturing Market Size is valued at 24.9 Billion in 2024 and is predicted to reach 80.0 Billion by the year 2034 at a 12.6% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Supportive regulatory frameworks and guidelines from agencies like the FDA and EMA encourage the adoption of next-generation biomanufacturing technologies. The ability to adapt fastly ...
Report ID: 1261 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Global Antisense Oligonucleotide Therapeutics Market Size is valued at USD 2.2 Billion in 2024 and is predicted to reach USD 9.1 Billion by the year 2034 at a 15.3% CAGR during the forecast period for 2025-2034. Antisense oligonucleotide is crucial in present medicine because it inhibits the expression of disease-causing genes by acting on messenger RNA before the protein is produced. This is attributed to rising antisense drug acceptability, ...
Report ID: 1245 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Global U.S. and Europe Concierge Medicine Market Size is valued at USD 11.1 Billion in 2024 and is predicted to reach USD 33.0 Billion by the year 2034 at a 11.8% CAGR during the forecast period for 2025-2034. Concierge medicine is an emerging healthcare business approach that includes the development of a connection between a patient and a healthcare professional. As a result, patients must pay an annual/monthly retainer fee in exchange for d...
Report ID: 1225 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Global Clinical Trials Software Market Size is valued at USD 0.9 Billion in 2024 and is predicted to reach USD 3.8 Billion by the year 2034 at a 15.8% CAGR during the forecast period for 2025-2034. Recently pharmaceutical companies started using clinical trial management services to improve the accuracy and efficiency of clinical trials. A clinical trial is a procedure that studies new treatments and drugs to check their effects on human healt...
Report ID: 1195 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Pharmaceuticals